zolmitriptan 5 mg

1 INDICATIONS AND USAGE Zolmitriptan tablets are indicated for the acute treatment of migraine with or without aura in adults. Limitations of Use: Only use zolmitriptan tablets if a clear diagnosis of migraine has been established. If a patient has no response to zolmitriptan tablets treatment for the first migraine attack, reconsider the diagnosis of migraine before zolmitriptan tablets are administered to treat any subsequent attacks. Zolmitriptan tablets are not indicated for the prevention of migraine attacks. Safety and effectiveness of zolmitriptan tablets have not been established for cluster headache. Zolmitriptan is a serotonin (5-HT) 1B/1D receptor agonist (triptan) indicated for the acute treatment of migraine with or without aura in adults ( 1 ) Limitations of Use: Use only after a clear diagnosis of migraine has been established ( 1 ) Not indicated for the prophylactic therapy of migraine ( 1 ) Not indicated for the treatment of cluster headache ( 1 )

Quality Care Products, LLC

FDA Reported Adverse Reactions
`[1] drug ineffective` `[2] adverse drug reaction` `[3] off label use` `[4] application site pruritus` `[5] headache` `[6] dizziness` `[7] condition aggravated` `[8] nausea` `[9] rash` `[10] dyspnoea`

4 weeks ago

ROUND YELLOW ZL 2

4 weeks ago

ZL 2 ROUND YELLOW

16 HOW SUPPLIED/STORAGE AND HANDLING 2.5 mg Tablets - pink, round, biconvex, film-coated tablets with "ZL 1" engraved on one side and break line on other side are supplied in cartons containing 6 tablets (55700-943-06). 5 mg Tablets - yellow, round, biconvex, film-coated tablets with "ZL 2" engraved on one side and plain on other side are supplied in cartons containing 3 tablets (55700-944-03). Store

ZOLMITRIPtan tablets at 20-25°C (68-77°F) [see USP Controlled Room Temperature]. Protect from light and moisture.

More pills like ROUND ZL 2

DISCLAIMER:

"This tool does not provide medical advice, and is for informational and educational purposes only, and is not a substitute for professional medical advice, treatment or diagnosis. Call your doctor to receive medical advice. If you think you may have a medical emergency, please dial 911."

"Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service."

"This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product."

PillSync may earn a commission via links on our site

zolmitriptan 5 mg

FDA Reported Adverse Reactions [1] drug ineffective [2] adverse drug reaction [3] off label use [4] application site pruritus [5] headache [6] dizziness [7] condition aggravated [8] nausea [9] rash [10] dyspnoea

ROUND YELLOW ZL 2

ZL 2 ROUND YELLOW

More pills like ROUND ZL 2

FDA Reported Adverse Reactions
`[1] drug ineffective` `[2] adverse drug reaction` `[3] off label use` `[4] application site pruritus` `[5] headache` `[6] dizziness` `[7] condition aggravated` `[8] nausea` `[9] rash` `[10] dyspnoea`